SectorBiological Technology
Established Date25/04/2008
Listing Date18/05/2017
ExchangeNASDAQ Stock Exchange
Full-time Employees1863
Fiscal Year Ends31/12
Security TypeDepository Receipts (Ordinary Shares)
Office addressLaarderhoogtweg 25, NL-1101 EB Amsterdam, Netherlands
Business
IntroductionArgenx Se was established on 25 April 2008 under the laws of the Netherlands as a private limited liability company (besloten vennootschap met beperkte aansprakelijkheid). On May 28, 2014, the company was converted into a public limited liability company (naamloze vennootschap) under the Notarized Conversion Deed and Amendment. The company is a commercial-stage, global, fully integrated biopharmaceutical company developing differentiated therapies for the treatment of serious autoimmune diseases.
